discovered that CD300ld on the surface of neutrophils was a crucial immune suppressor for tumor‐related immunosuppression.[183] The results showed that the inhibition of CD300ld activity suppressed tumor development and exhibited a synergetic effect with anti‐PD‐1 therapy. This evidence concerns the gene CD300LD and neoplasm.